Bluetongue virus recombinant vaccines and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9345759
APP PUB NO 20110236420A1
SERIAL NO

13046317

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention encompasses BTV vaccines or compositions. The vaccine or composition may be a vaccine or composition containing BTV antigens. The invention also encompasses recombinant vectors encoding and expressing BTV antigens, epitopes or immunogens which can be used to protect animals, such as ovines, bovines, or caprines, against BTV.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERIAL INC3239 SATELLITE BLVD DULUTH GA 30096

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Audonnet, Jean-Christophe Lyons, FR 39 173
Cox, Kevin Raleigh, US 16 541
Guo, Xuan Suwanee, US 39 96

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00